Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.85 USD | -1.42% | -4.34% | -13.70% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
Financials (USD)
Sales 2024 * | 48.84M | Sales 2025 * | 53.68M | Capitalization | 65.93M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.35 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.79% |
Latest transcript on Champions Oncology, Inc.
1 day | -1.42% | ||
1 week | -4.34% | ||
1 month | -1.02% | ||
3 months | -16.52% | ||
6 months | -11.17% | ||
Current year | -13.70% |
Managers | Title | Age | Since |
---|---|---|---|
Ronnie Morris
CEO | Chief Executive Officer | 58 | 10-10-25 |
Brady Davis
PSD | President | - | 23-10-16 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
FOU | Founder | 64 | 07-12-31 |
Scott Tobin
BRD | Director/Board Member | 53 | 11-06-26 |
Joel Ackerman
CHM | Chairman | 59 | 10-10-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 4.85 | -1.42% | 826 |
24-04-29 | 4.92 | -1.99% | 4,629 |
24-04-26 | 5.02 | -0.79% | 1,620 |
24-04-25 | 5.06 | +0.60% | 1,477 |
24-04-24 | 5.03 | -0.79% | 1,377 |
Delayed Quote Nasdaq, April 30, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-13.70% | 65.93M | |
+0.17% | 42.19B | |
+10.92% | 42.24B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B |
- Stock Market
- Equities
- CSBR Stock